Literature DB >> 25042632

Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model.

Irena Slavuljica1, Daria Kveštak2, Peter Csaba Huszthy3, Kate Kosmac4, William J Britt4, Stipan Jonjić2.   

Abstract

Congenital human cytomegalovirus infection is a leading infectious cause of long-term neurodevelopmental sequelae, including mental retardation and hearing defects. Strict species specificity of cytomegaloviruses has restricted the scope of studies of cytomegalovirus infection in animal models. To investigate the pathogenesis of congenital human cytomegalovirus infection, we developed a mouse cytomegalovirus model that recapitulates the major characteristics of central nervous system infection in human infants, including the route of neuroinvasion and neuropathological findings. Following intraperitoneal inoculation of newborn animals with mouse cytomegalovirus, the virus disseminates to the central nervous system during high-level viremia and replicates in the brain parenchyma, resulting in a focal but widespread, non-necrotizing encephalitis. Central nervous system infection is coupled with the recruitment of resident and peripheral immune cells as well as the expression of a large number of pro-inflammatory cytokines. Although infiltration of cellular constituents of the innate immune response characterizes the early immune response in the central nervous system, resolution of productive infection requires virus-specific CD8(+) T cells. Perinatal mouse cytomegalovirus infection results in profoundly altered postnatal development of the mouse central nervous system and long-term motor and sensory disabilities. Based on an enhanced understanding of the pathogenesis of this infection, prospects for novel intervention strategies aimed to improve the outcome of congenital human cytomegalovirus infection are proposed.

Entities:  

Mesh:

Year:  2014        PMID: 25042632      PMCID: PMC4654296          DOI: 10.1038/cmi.2014.51

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  148 in total

Review 1.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns.

Authors:  Mark R Schleiss
Journal:  ILAR J       Date:  2006

3.  Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age.

Authors:  Silvia Visentin; Renzo Manara; Laura Milanese; Anna Da Roit; Gabriella Forner; Eleonora Salviato; Valentina Citton; Fioretta Marciani Magno; Eva Orzan; Carla Morando; Riccardo Cusinato; Carlo Mengoli; Giorgio Palu; Mario Ermani; Roberto Rinaldi; Erich Cosmi; Nadia Gussetti
Journal:  Clin Infect Dis       Date:  2012-04-26       Impact factor: 9.079

4.  Disordered migration and loss of virus-infected neuronal cells in developing mouse brains infected with murine cytomegalovirus.

Authors:  Y Shinmura; I Kosugi; S Aiba-Masago; S Baba; L R Yong; Y Tsutsui
Journal:  Acta Neuropathol       Date:  1997-06       Impact factor: 17.088

5.  Depolarization strongly induces human cytomegalovirus major immediate-early promoter/enhancer activity in neurons.

Authors:  D G Wheeler; E Cooper
Journal:  J Biol Chem       Date:  2001-06-07       Impact factor: 5.157

6.  Congenital cytomegalovirus infection: audiologic outcome.

Authors:  Karen B Fowler
Journal:  Clin Infect Dis       Date:  2013-12       Impact factor: 9.079

Review 7.  Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis.

Authors:  James R Lokensgard; Maxim C-J Cheeran; Shuxian Hu; Genya Gekker; Phillip K Peterson
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

8.  Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirus.

Authors:  Y Shinmura; S Aiba-Masago; I Kosugi; R Y Li; S Baba; Y Tsutsui
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

Review 9.  Effects of cytomegalovirus infection on embryogenesis and brain development.

Authors:  Yoshihiro Tsutsui
Journal:  Congenit Anom (Kyoto)       Date:  2009-06       Impact factor: 1.409

10.  Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population.

Authors:  Marisa M Mussi-Pinhata; Aparecida Y Yamamoto; Rosângela M Moura Brito; Myriam de Lima Isaac; Patricia F de Carvalho e Oliveira; Suresh Boppana; William J Britt
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

View more
  32 in total

1.  GWAS, cytomegalovirus infection, and schizophrenia.

Authors:  Jakob Grove; Anders D Børglum; Brad D Pearce
Journal:  Curr Behav Neurosci Rep       Date:  2014-12-01

2.  CMV immunology.

Authors:  Stipan Jonjic
Journal:  Cell Mol Immunol       Date:  2015-01-12       Impact factor: 11.530

3.  CD4 T cells are required for maintenance of CD8 TRM cells and virus control in the brain of MCMV-infected newborn mice.

Authors:  Ilija Brizić; Lea Hiršl; Marko Šustić; Mijo Golemac; William J Britt; Astrid Krmpotić; Stipan Jonjić
Journal:  Med Microbiol Immunol       Date:  2019-03-28       Impact factor: 3.402

Review 4.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

5.  Immunometabolic phenotype of BV-2 microglia cells upon murine cytomegalovirus infection.

Authors:  Natalia Kučić; Valentino Rački; Kristina Jurdana; Marina Marcelić; Kristina Grabušić
Journal:  J Neurovirol       Date:  2019-04-25       Impact factor: 2.643

Review 6.  MicroRNA 155 and viral-induced neuroinflammation.

Authors:  Laura L Dickey; Timothy M Hanley; Thomas B Huffaker; Andrew G Ramstead; Ryan M O'Connell; Thomas E Lane
Journal:  J Neuroimmunol       Date:  2017-01-24       Impact factor: 3.478

Review 7.  Immune responses to congenital cytomegalovirus infection.

Authors:  Ilija Brizić; Lea Hiršl; William J Britt; Astrid Krmpotić; Stipan Jonjić
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

8.  Rodent Models of Congenital Cytomegalovirus Infection.

Authors:  Berislav Lisnić; Jelena Tomac; Djurdjica Cekinović; Stipan Jonjić; Vanda Juranić Lisnić
Journal:  Methods Mol Biol       Date:  2021

Review 9.  Models of vertical cytomegalovirus (CMV) transmission and pathogenesis.

Authors:  Yiska Weisblum; Amos Panet; Ronit Haimov-Kochman; Dana G Wolf
Journal:  Semin Immunopathol       Date:  2014-10-08       Impact factor: 9.623

10.  Mood stabilizers inhibit cytomegalovirus infection.

Authors:  Sara Ornaghi; John N Davis; Kelly L Gorres; George Miller; Michael J Paidas; Anthony N van den Pol
Journal:  Virology       Date:  2016-09-19       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.